U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert A. Bradway said at the ...

LONDON (Reuters) - The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases including HIV and malaria in some of the world's poorest ...

HYDERABAD, India (Reuters) - Indian pharmaceutical companies will be able to retain their dominant market share in the U.S.

Indian drugmakers are hoping that bilateral discussions between the country and the United States will help them steer clear ...

Thousands of investors in India are scrambling to recoup nearly $100 million after they were caught in a Ponzi scheme that ...